Idexx Laboratories (IDXX) Long-Term Deferred Tax (2016 - 2018)

Idexx Laboratories' Long-Term Deferred Tax history runs 9 years deep, the most recent figure standing at $83.4 million for Q1 2018.

• In Q1 2018, Long-Term Deferred Tax rose 1321.8% year-over-year to $83.4 million; the TTM figure through Mar 2018 stood at $83.4 million (up 1321.8% YoY), while the FY2017 annual figure was $7.7 million, up 34.89% from the prior year.
• Long-Term Deferred Tax for Q1 2018 stood at $83.4 million, up from $7.7 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $83.4 million in Q1 2018, with the low at $5.7 million in Q4 2016.
• The 5-year median for Long-Term Deferred Tax is $28.2 million (2014), against an average of $29.7 million.
• The sharpest annual moves came in 2017 and 2018: Long-Term Deferred Tax sank 87.15% in 2017, then soared 1321.8% in 2018.
• Idexx Laboratories' Long-Term Deferred Tax stood at $28.2 million in 2014, then soared by 54.7% to $43.6 million in 2015, then plunged by 86.9% to $5.7 million in 2016, then soared by 34.89% to $7.7 million in 2017, then jumped by 983.62% to $83.4 million in 2018.
• Business Quant data shows IDXX's Long-Term Deferred Tax at $83.4 million in Q1 2018, $7.7 million in Q4 2017, and $7.9 million in Q3 2017.